Arphra AIPlain-English read on Vertex Pharmaceuticals Incorporated’s valuation
Valuation read
Valuation snapshot
Each multiple is placed against its own 5-year range (the dot is the historical percentile of today’s value) and the peer-set sector median. key_metrics_ttm
Multiples · current vs 5-year range vs sector
marker = today’s percentile · sector = peer median
Metric
Current
5-year range
%ile
Sector
Read
P / E (TTM)
—
—
—
—
—
PEG
—
—
—
—
—
EV / EBITDA
—
—
—
—
—
EV / Sales
8.7×
8.7
9.0
33
2.9×
premium to sector
P / S
—
—
—
—
—
P / B
—
—
—
—
—
EV / FCF
28.9×
28.9
33.4
33
17.6×
premium to sector
FCF yield
3.36%
3.0
3.4
100
6.38%
rich vs its history
Pro
Multiples
Valuation multiples and peer comparisons are included with Pro.